Screener
NeoGenomics NEO Balance Sheet Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $139.28M-15.1% | $145.54M-5.9% | $146.14M-57.8% | $159.62M-56.5% | $164.12M-54.7% | ||
| $213.41M+37.4% | $175.41M+14.6% | $167.42M+10.7% | $159.24M+5.8% | $155.3M+2.6% | ||
| $25.5M-10.4% | $27.14M-20.6% | $29.84M+0.2% | $28.57M+6.8% | $28.46M+16.4% | ||
| $410.08M+7.2% | $381.48M-2.8% | $373.68M-34.9% | $376.29M-36.9% | $382.47M-35.2% | ||
| $85.94M+0.6% | $80.94M-5.3% | $83.66M-6.6% | $84.83M-9.8% | $85.47M-8.1% | ||
| $524M-0.1% | $524M0.0% | $524M+0.2% | $524.34M+0.3% | $524.34M+0.3% | ||
| $263.63M-6.1% | $257.82M-10.6% | $265.45M-16.5% | $286.53M-15.6% | $280.72M-19.3% | ||
| $966.83M-2.6% | $970.77M-3.1% | $972.85M-5.3% | $983.54M-5.6% | $992.32M-5.6% | ||
| $1.38B+0.2% | $1.35B-3.0% | $1.35B-15.9% | $1.36B-17.0% | $1.37B-16.2% | ||
| $32.93M+45.6% | $20.95M-23.8% | $25.9M+59.8% | $23.09M+6.9% | $22.61M+36.9% | ||
| $267K-83.1% | $194K-82.1% | $561K-51.8% | $851K+108% | $1.58M+168% | ||
| $1.7M— | $1.7M— | —— | $0-100% | —— | ||
| $116.17M+18.7% | $105.88M+5.8% | $84.59M-69.8% | $88.3M-70.7% | $97.87M-67.0% | ||
| —— | $374.24M— | —— | $341.86M— | —— | ||
| $460.11M+4.9% | $460.63M+4.7% | $433.18M-0.1% | $434.97M+0.1% | $438.62M+0.5% | ||
| $576.28M+7.4% | $566.51M+4.9% | $517.77M-27.4% | $523.27M-28.9% | $536.49M-26.8% | ||
| $131K+2.3% | $130K+1.6% | $129K+0.8% | $129K+0.8% | $128K0.0% | ||
| -$456.22M-7.6% | -$448.67M-13.1% | -$450.91M-28.2% | -$433.81M-33.2% | -$423.93M-36.5% | ||
| $800.64M-4.5% | $785.73M-8.0% | $828.76M-6.7% | $836.56M-7.3% | $838.29M-7.7% | ||
| $1.38B+0.2% | $1.35B-3.0% | $1.35B-15.9% | $1.36B-17.0% | $1.37B-16.2% |
FAQ
- What are NeoGenomics's total assets?
- NeoGenomics (NEO) holds $1.4B in total assets, up 0.2% year over year.
- How much debt does NeoGenomics have?
- NeoGenomics carries $74.5M in total debt against $800.6M of shareholders' equity, a debt-to-equity ratio of 0.09.
- How much cash does NeoGenomics have?
- NeoGenomics holds $139.3M in cash and equivalents.
- Can NeoGenomics cover its short-term obligations?
- Its current ratio is 3.53 — current assets exceed current liabilities.
- Where does NeoGenomics's balance sheet data come from?
- Every line is extracted from NeoGenomics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
